Li Z-Q, Qu M, Wan H-X, Wang H, Deng Q, Zhang Y
Department of Oncology, Sanya People's Hospital, Sanya, China.
Eur Rev Med Pharmacol Sci. 2021 Mar;25(5):2159. doi: 10.26355/eurrev_202103_25247.
We detected some serious inaccuracies and mistakes. Therefore, the article "FOXK1 promotes malignant progression of breast cancer by activating PI3K/AKT/mTOR signaling pathway, by Z.-Q. Li, M. Qu, H.-X. Wan, H. Wang, Q. Deng, Y. Zhang, published in Eur Rev Med Pharmacol Sci 2019; 23 (22): 9978-9987-DOI: 10.26355/eurrev_201911_19564-PMID: 31799667" has been withdrawn. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/19564.
我们发现了一些严重的不准确之处和错误。因此，发表于《欧洲医学与药理学评论》2019年；23(22):9978 - 9987 - DOI: 10.26355/eurrev_201911_19564 - PMID: 31799667，题为“FOXK1通过激活PI3K/AKT/mTOR信号通路促进乳腺癌的恶性进展，作者Z.-Q. Li、M. Qu、H.-X. Wan、H. Wang、Q. Deng、Y. Zhang”的文章已被撤回。出版商对由此可能造成的任何不便表示歉意。https://www.europeanreview.org/article/19564 。
